{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:21:27Z","timestamp":1770841287510,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102542"],"award-info":[{"award-number":["82102542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Post-Doctor Research Project, West China Hospital, Sichuan University","award":["2020HXBH08"],"award-info":[{"award-number":["2020HXBH08"]}]},{"name":"Fellowship of China Postdoctoral Science Foundation","award":["2021M692283"],"award-info":[{"award-number":["2021M692283"]}]},{"name":"Sichuan Cadre Health Research Project","award":["2022-118 2"],"award-info":[{"award-number":["2022-118 2"]}]},{"name":"Sichuan Traditional Chinese Medicine Administration","award":["2021MS122"],"award-info":[{"award-number":["2021MS122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Calcaneal fractures are a common orthopedic disease, account for approximately 2% of all bone fractures, and represent 60% of fractures of tarsal bones. Tranexamic acid (TXA) is a synthetic antifibrinolytic drug that competitively blocks the lysine-binding sites of plasminogen, plasmin, and tissue plasminogen activator, delaying fibrinolysis and blood clot degradation. However, the effect of TXA on patients with calcaneal surgery remains controversial. Our objective was to evaluate the effectiveness of TXA in calcaneal fractures surgeries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The electronic literature databases of Pubmed, Embase, and Cochrane library were searched in December 2022. The data on blood loss, the stay in the hospital, the duration of surgery, hemoglobin, hematocrit, platelet count, prothrombin time, activated partial thromboplastin time, and wound complication were extracted. The Stata 22.0 software was used for the meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four randomized controlled studies met our inclusion criteria. This meta-analysis showed that TXA significantly reduced postoperative blood loss during the first 24\u00a0h (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), improved the level of hemoglobin (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and hematocrit (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), and reduced the risk of wound complications (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). There was no significant difference between the two groups regarding total and intraoperative blood loss, hospital stay, duration of surgery, platelet count, activated partial thromboplastin time, and prothrombin time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TXA significantly reduced blood loss during the first 24\u00a0h postoperatively, improved the level of hemoglobin and hematocrit, and reduced the risk of wound complications. Given the evidence, TXA can be used in patients with calcaneal fractures and had the potential benefit of blood reduction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Protocol registration<\/jats:title>\n                <jats:p>The protocol was registered in PROSPERO (registration No. CRD42023391211).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03924-0","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T08:01:45Z","timestamp":1689148905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of perioperative tranexamic acid (TXA) in patients with calcaneal fractures: a meta-analysis and systematic review of randomized controlled trials"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiumei","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"3924_CR1","doi-asserted-by":"publisher","first-page":"887386","DOI":"10.3389\/fphar.2022.887386","volume":"13","author":"P Hong","year":"2022","unstructured":"Hong P, Liu R, Rai S, Liu J, Ding Y, Li J. Does tranexamic acid reduce the blood loss in various surgeries? An umbrella review of state-of-the-art meta-analysis. Front Pharmacol. 2022;13:887386.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3924_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00264-022-05384-3","volume":"46","author":"C Biz","year":"2022","unstructured":"Biz C, Refolo M, Zinnarello FD, Crim\u00ec A, Dante F, Ruggieri P. A historical review of calcaneal fractures: from the crucifixion of Jesus Christ and Don Juan injuries to the current plate osteosynthesis. Int Orthop. 2022;46(6):1413\u201322.","journal-title":"Int Orthop"},{"key":"3924_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1053\/j.jfas.2022.01.017","volume":"61","author":"J Huang","year":"2022","unstructured":"Huang J, Guo H, Huang W, Tan X, Huang H, Zeng C. Topical application of tranexamic acid can reduce postoperative blood loss in calcaneal fractures: a randomized controlled trial. J Foot Ankle Surg. 2022;61:1056.","journal-title":"J Foot Ankle Surg"},{"issue":"6","key":"3924_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.jfas.2015.07.006","volume":"54","author":"B Xie","year":"2015","unstructured":"Xie B, Tian J, Zhou DP. Administration of tranexamic acid reduces postoperative blood loss in calcaneal fractures: a randomized controlled trial. J Foot Ankle Surg. 2015;54(6):1106\u201310.","journal-title":"J Foot Ankle Surg"},{"issue":"5","key":"3924_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2106\/JBJS.18.00128","volume":"101","author":"D Wang","year":"2019","unstructured":"Wang D, Wang HY, Luo ZY, Pei FX, Zhou ZK, Zeng WN. Finding the optimal regimen for oral tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2019;101(5):438\u201345.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"3924_CR6","doi-asserted-by":"publisher","first-page":"13579","DOI":"10.1038\/s41598-018-31791-x","volume":"8","author":"D Wang","year":"2018","unstructured":"Wang D, Wang HY, Cao C, Li LL, Meng WK, Pei FX, Li DH, Zhou ZK, Zeng WN. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. Sci Rep. 2018;8(1):13579.","journal-title":"Sci Rep"},{"issue":"1","key":"3924_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-0038-1676625","volume":"119","author":"D Wang","year":"2019","unstructured":"Wang D, Yang Y, He C, Luo ZY, Pei FX, Li Q, Zhou ZK, Zeng WN. Effect of multiple doses of oral tranexamic acid on haemostasis and inflammatory reaction in total hip arthroplasty: a randomized controlled trial. Thromb Haemost. 2019;119(1):92\u2013103.","journal-title":"Thromb Haemost"},{"issue":"3","key":"3924_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.arth.2017.09.062","volume":"33","author":"ZY Luo","year":"2018","unstructured":"Luo ZY, Wang HY, Wang D, Zhou K, Pei FX, Zhou ZK. Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind. Controll Study J Arthroplast. 2018;33(3):786\u201393.","journal-title":"Controll Study J Arthroplast"},{"key":"3924_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.04.026","volume":"167","author":"ZY Luo","year":"2018","unstructured":"Luo ZY, Wang D, Meng WK, Wang HY, Pan H, Pei FX, Zhou ZK. Oral tranexamic acid is equivalent to topical tranexamic acid without drainage in primary total hip arthroplasty: a double-blind randomized clinical trial. Thromb Res. 2018;167:1\u20135.","journal-title":"Thromb Res"},{"key":"3924_CR10","doi-asserted-by":"publisher","first-page":"110020","DOI":"10.1016\/j.jclinane.2020.110020","volume":"67","author":"YT Yao","year":"2020","unstructured":"Yao YT, He LX, Tan JC. The effect of tranexamic acid on the values of activated clotting time in patients undergoing cardiac surgery: a PRISMA-compliant systematic review and meta-analysis. J Clin Anesth. 2020;67:110020.","journal-title":"J Clin Anesth"},{"issue":"9","key":"3924_CR11","doi-asserted-by":"publisher","first-page":"e28966","DOI":"10.1097\/MD.0000000000028966","volume":"101","author":"ZY Zou","year":"2022","unstructured":"Zou ZY, He LX, Yao YT. Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2022;101(9):e28966.","journal-title":"Medicine"},{"issue":"2","key":"3924_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.spinee.2020.10.011","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Wang LN, Yang X, Liu LM, Xiu P, Zhou ZJ, Wang L, Song YM. The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial. Spine J. 2021;21(2):312\u201320.","journal-title":"Spine J"},{"issue":"4","key":"3924_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3171\/2021.7.SPINE202217","volume":"36","author":"NJ Brown","year":"2022","unstructured":"Brown NJ, Choi EH, Gendreau JL, Ong V, Himstead A, Lien BV, Shahrestani S, Ransom SC, Tran K, Tafreshi AR, et al. Association of tranexamic acid with decreased blood loss in patients undergoing laminectomy and fusion with posterior instrumentation: a systematic review and meta-analysis. J Neurosurg Spine. 2022;36(4):686\u201393.","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"3924_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12871-019-0761-3","volume":"19","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Bai Y, Chen M, Zhou Y, Yu X, Zhou H, Chen G. The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): a meta-analysis of 28 randomized controlled trials. BMC Anesthesiol. 2019;19(1):104.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"3924_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12959-022-00373-3","volume":"20","author":"DF Draxler","year":"2022","unstructured":"Draxler DF, Hanafi G, Zahra S, McCutcheon F, Ho H, Keragala CB, Liu Z, Daly D, Painter T, Wallace S, et al. Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery. Thromb J. 2022;20(1):17.","journal-title":"Thromb J"},{"issue":"1","key":"3924_CR16","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.1038\/s41598-022-13861-3","volume":"12","author":"G Tan","year":"2022","unstructured":"Tan G, Xie LW, Yi SJ, Chen Y, Liu X, Zhang H. The efficacy and safety of intravenous tranexamic acid on blood loss during total ankle replacement: a retrospective study. Sci Rep. 2022;12(1):9542.","journal-title":"Sci Rep"},{"issue":"5","key":"3924_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1148\/rg.255045713","volume":"25","author":"A Daftary","year":"2005","unstructured":"Daftary A, Haims AH, Baumgaertner MR. Fractures of the calcaneus: a review with emphasis on CT. Radiographics. 2005;25(5):1215\u201326.","journal-title":"Radiographics"},{"issue":"1","key":"3924_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fcl.2016.09.007","volume":"22","author":"MP Clare","year":"2017","unstructured":"Clare MP, Crawford WS. Managing complications of calcaneus fractures. Foot Ankle Clin. 2017;22(1):105\u201316.","journal-title":"Foot Ankle Clin"},{"issue":"1","key":"3924_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/SLA.0000000000003793","volume":"273","author":"M Heyns","year":"2021","unstructured":"Heyns M, Knight P, Steve AK, Yeung JK. A single preoperative dose of tranexamic acid reduces perioperative blood loss: a meta-analysis. Ann Surg. 2021;273(1):75\u201381.","journal-title":"Ann Surg"},{"key":"3924_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010562.pub2","author":"K Ker","year":"2013","unstructured":"Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010562.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3924_CR21","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.arth.2018.04.043","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33(10):3090-3098.e3091.","journal-title":"J Arthroplasty"},{"key":"3924_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jocn.2018.10.121","volume":"61","author":"K Yerneni","year":"2019","unstructured":"Yerneni K, Burke JF, Tuchman A, Li XJ, Metz LN, Lehman RA Jr, Lenke LG, Tan LA. Topical tranexamic acid in spinal surgery: a systematic review and meta-analysis. J Clin Neurosci. 2019;61:114\u20139.","journal-title":"J Clin Neurosci"},{"issue":"10","key":"3924_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1177\/10711007221114139","volume":"43","author":"M Salameh","year":"2022","unstructured":"Salameh M, Attia AK, El Khatib S, Hantouly A, Hsu R, Blankenhorn B. Tranexamic acid utilization in foot and ankle surgery: a meta-analysis. Foot Ankle Int. 2022;43(10):1370\u20138.","journal-title":"Foot Ankle Int"},{"issue":"Suppl 1","key":"3924_CR24","first-page":"S301","volume":"62","author":"I Prudovsky","year":"2022","unstructured":"Prudovsky I, Kacer D, Zucco VV, Palmeri M, Falank C, Kramer R, Carter D, Rappold J. Tranexamic acid: beyond antifibrinolysis. Transfusion. 2022;62(Suppl 1):S301-s312.","journal-title":"Transfusion"},{"issue":"2","key":"3924_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3928\/01477447-20160301-05","volume":"39","author":"ZX Lin","year":"2016","unstructured":"Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016;39(2):119\u201330.","journal-title":"Orthopedics"},{"issue":"5","key":"3924_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.knee.2017.07.004","volume":"24","author":"JA Jansen","year":"2017","unstructured":"Jansen JA, Lameijer JRC, Snoeker BAM. Combined intravenous, topical and oral tranexamic acid administration in total knee replacement: evaluation of safety in patients with previous thromboembolism and effect on hemoglobin level and transfusion rate. Knee. 2017;24(5):1206\u201312.","journal-title":"Knee"},{"issue":"5","key":"3924_CR27","doi-asserted-by":"publisher","first-page":"e12546","DOI":"10.1002\/rth2.12546","volume":"5","author":"N Relke","year":"2021","unstructured":"Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: an illustrated review. Res Pract Thromb Haemost. 2021;5(5):e12546.","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"3924_CR28","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/j.surge.2020.10.003","volume":"19","author":"N Gougoulias","year":"2021","unstructured":"Gougoulias N, McBride D, Maffulli N. Outcomes of management of displaced intra-articular calcaneal fractures. Surgeon. 2021;19(5):e222\u20139. https:\/\/doi.org\/10.1016\/j.surge.2020.10.003.","journal-title":"Surgeon"},{"key":"3924_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/bmb\/ldp030","volume":"92","author":"N Gougoulias","year":"2009","unstructured":"Gougoulias N, Khanna A, McBride DJ, Maffulli N. Management of calcaneal fractures: systematic review of randomized trials. Br Med Bull. 2009;92:153\u201367. https:\/\/doi.org\/10.1093\/bmb\/ldp030.","journal-title":"Br Med Bull"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03924-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T08:05:38Z","timestamp":1689149138000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3924"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03924-0","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This meta-analysis and all the included studies meet all the ethical standards described in the declaration of Helsinki. No ethical committee approval was required for this study. All methods were performed in accordance with the relevant guidelines and regulations. And all authors have stated for consents of publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}